Q1 2024 Accelerate Diagnostics Inc Earnings Call Transcript
Good day and welcome to the Accelerate Diagnostics, Inc. First Quarter 2024 Results Conference Call. All participants will be in a listen only mode. After today's presentation, there will be an opportunity to ask questions with our covering analysts. I would now like to turn the conference over to Ms. Laura Pierson of Accelerate Diagnostics. Please go ahead, ma'am.
Before we begin it is important to share that information presented during this call may contain forward-looking statements within the meaning of Section 27 A. of the Securities Act of 1933 and Section 21 E. of the Securities Exchange Act of 1934. Forward-looking statements include projections statements about our future and those that are not historical facts. All forward-looking statements are made during this conference call are subject to risks, uncertainties and other factors that could cause our actual results to differ materially. These are discussed in greater detail in our annual report on Form 10 K for the year ended December 31st, 2023, and other
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |